Journal of Lipid Research, Vol 33, 1527-1539, Copyright © 1992 by Lipid Research, Inc.

ARTICLES

Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids

H Gylling, GL Vega and SM Grundy
Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas 75235-9052.

Low plasma concentrations of high density lipoprotein (HDL) cholesterol and apolipoprotein A-I (apoA-I) are major risk factors for coronary heart disease (CHD). Low HDL levels are common in patients with hypertriglyceridemia, but they also occur in those with normal plasma lipids; the latter include obese patients and cigarette smokers, though other patients with low HDL levels are neither obese nor smokers. The present study was designed to define metabolic causes of low apoA-I levels in normal-weight, normolipidemic patients. ApoA-I tracer studies were carried out in two groups of normolipidemic patients having low HDL levels to determine input rates and residence times for ApoA-I; these patients included 11 nonobese nonsmokers and 11 nonobese cigarette smokers. Their results were compared to those of 20 normal- weight, normolipidemic controls with normal HDL levels and 12 obese nonsmokers also having low HDL. In all three groups manifesting low HDL- cholesterol and low apoA-I levels, residence times for plasma apoA-I were reduced by approximately 30%, compared to control subjects with normal HDL levels. In contrast, average input rates for apoA-I were similar among the three low-HDL patients and control subjects. No differences in apoA-I kinetics were observed among any of the three groups with low apoA-I concentrations. Within each of the four groups of the study, however, input rates for apoA-I were highly correlated with plasma concentrations of apoA-I. Thus, for individuals with normal levels of plasma lipids, both residence times and input rates for apoA- I appeared to be important determinants of apoA-I levels. Residence times for apoA-I were reduced in almost all patients with low apoA-I levels, regardless of concomitant factors, whereas input rates were highly variable among individuals.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Hovorka, M. N. Nanjee, C. J. Cooke, I. P. Miller, W. L. Olszewski, and N. E. Miller Mass kinetics of apolipoprotein A-I in interstitial fluid after administration of intravenous apolipoprotein A-I/lecithin discs in humans J. Lipid Res., May 1, 2006; 47(5): 975 - 981. [Abstract] [Full Text] [PDF]

				M. C. de Beer, D. van der Westhuyzen, N. L. Whitaker, N. R. Webb, and F. C. de Beer SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism J. Lipid Res., October 1, 2005; 46(10): 2143 - 2150. [Abstract] [Full Text] [PDF]

				K. Okubo, K. Ikewaki, S. Sakai, N. Tada, Y. Kawaguchi, and S. Mochizuki Abnormal HDL Apolipoprotein A-I and A-II Kinetics in Hemodialysis Patients: A Stable Isotope Study J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1008 - 1015. [Abstract] [Full Text] [PDF]

				S. Bilz, S. Wagner, M. Schmitz, A. Bedynek, U. Keller, and T. Demant Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia J. Lipid Res., January 1, 2004; 45(1): 174 - 185. [Abstract] [Full Text] [PDF]

				P. Simonen, H. Gylling, A. N Howard, and T. A Miettinen Introducing a new component of the metabolic syndrome: low cholesterol absorption Am. J. Clinical Nutrition, July 1, 2000; 72(1): 82 - 88. [Abstract] [Full Text] [PDF]

				U. J. F. Tietge, C. Maugeais, W. Cain, D. Grass, J. M. Glick, F. C. de Beer, and D. J. Rader Overexpression of Secretory Phospholipase A2 Causes Rapid Catabolism and Altered Tissue Uptake of High Density Lipoprotein Cholesteryl Ester and Apolipoprotein A-I J. Biol. Chem., March 31, 2000; 275(14): 10077 - 10084. [Abstract] [Full Text] [PDF]

				W. Velez-Carrasco, A. H. Lichtenstein, Z. Li, G. G. Dolnikowski, S. Lamon-Fava, F. K. Welty, and E. J. Schaefer Apolipoprotein A-I and A-II Kinetic Parameters as Assessed by Endogenous Labeling With [2H3]Leucine in Middle-Aged and Elderly Men and Women Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 801 - 806. [Abstract] [Full Text] [PDF]

				M. N. Nanjee and E. A. Brinton Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography Clin. Chem., February 1, 2000; 46(2): 207 - 223. [Abstract] [Full Text] [PDF]

				E. R. De Oliveirae Silva, M. Kong, Z. Han, C. Starr, E. M. Kass, S.-H. H. Juo, D. Foster, H. M. Dansky, M. Merkel, K. Cundey, et al. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females J. Lipid Res., July 1, 1999; 40(7): 1211 - 1221. [Abstract] [Full Text]

				M. N. Nanjee, J. E. Doran, P. G. Lerch, and N. E. Miller Acute Effects of Intravenous Infusion of ApoA1/Phosphatidylcholine Discs on Plasma Lipoproteins in Humans Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 979 - 989. [Abstract] [Full Text] [PDF]

				M. Tilly-Kiesi, A. H. Lichtenstein, J. Joven, E. Vilella, M. C. Cheung, W. V. Carrasco, J. M. Ordovas, G. Dolnikowski, and E. J. Schaefer Impact of Gender on the Metabolism of Apolipoprotein A-I in HDL Subclasses LpAI and LpAI:AII in Older Subjects Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3513 - 3518. [Abstract] [Full Text]

				H. E. Miettinen, M. Jauhiainen, H. Gylling, S. Ehnholm, A. Palomaki, T. A. Miettinen, and K. Kontula Apolipoprotein A-IFIN (Leu159->Arg) Mutation Affects Lecithin : Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3021 - 3032. [Abstract] [Full Text]

				M. Tilly-Kiesi, A. H. Lichtenstein, J. M. Ordovas, G. Dolnikowski, R. Malmstrom, M.-R. Taskinen, and E. J. Schaefer Subjects With ApoA-I(Lys107->0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII) Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 873 - 880. [Abstract] [Full Text]

				H. E. Miettinen, H. Gylling, T. A. Miettinen, J. Viikari, L. Paulin, and K. Kontula Apolipoprotein A-IFin: Dominantly Inherited Hypoalphalipoproteinemia Due to a Single Base Substitution in the Apolipoprotein A-I Gene Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 83 - 90. [Abstract] [Full Text]

				M.N. Nanjee, J.R. Crouse, J.M. King, R. Hovorka, S.E. Rees, E.R. Carson, J.-J. Morgenthaler, P. Lerch, and N.E. Miller Effects of Intravenous Infusion of Lipid-Free Apo A-I in Humans Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1203 - 1214. [Abstract] [Full Text]

				F. Tato, G. L. Vega, and S. M. Grundy Bimodal Distribution of Cholesteryl Ester Transfer Protein Activities in Normotriglyceridemic Men With Low HDL Cholesterol Concentrations Arterioscler. Thromb. Vasc. Biol., April 1, 1995; 15(4): 446 - 451. [Abstract] [Full Text]

				K. Ikewaki, L. A. Zech, M. Kindt, H. B. Brewer Jr, and D. J. Rader Apolipoprotein A-II Production Rate Is a Major Factor Regulating the Distribution of Apolipoprotein A-I Among HDL Subclasses LpA-I and LpA-I:A-II in Normolipidemic Humans Arterioscler. Thromb. Vasc. Biol., March 1, 1995; 15(3): 306 - 312. [Abstract] [Full Text]